Anticoagulants in Acute Myocardial Infarction

  • Daniel Deykin


Anticoagulants in the treatment and prevention of acute myocardial infarction were initially advocated for three potential therapeutic benefits: lowering case fatality rate by limitation of infarct size, prevention of recurrent infarction, and reduction of thromboembolic complications.1 Despite early enthusiasm for their use, anticoagulants are now rarely employed in the in-hospital phase of management of patients with acute myocardial infarction.2 A recent survey of the Section on Clinical Cardiology of the American College of Chest Physicians3 revealed that fewer than 10 percent of respondents used warfarin routinely, and 65 percent rarely administered warfarin during hospitalization for acute myocardial infarction. Of those who did use warfarin, there was a clear association with the age of the physician. Only two percent of physicians under the age of 40 used warfarin routinely, whereas 25 percent of physicians over 60 favored its administration. The reasons for the striking repudiation of anticoagulant therapy relate primarily to mistrust of earlier insistence on its benefits, and apprehension over its risks. Nevertheless, recent consensus statements and editorial opinions reemphasize that there is a clear-cut role for anticoagulants in the management of acute myocardial infarction: reduction of the incidence of systemic embolization in those selectively at risk.


Acute Myocardial Infarction Anticoagulant Therapy Systemic Embolus Mural Thrombus Left Ventricular Thrombus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    I. S. Wright, C.D. Marple, and D. F. Beck, Report of the committee for the evaluation of anticoagulants in the treatment of coronary-thrombosis with myocardial infarction, Am. Heart J. 36:801 (1948).PubMedCrossRefGoogle Scholar
  2. 2.
    J. R. A. Mitchell, Anticoagulants in coronary heart disease — retrospect and prospect, Lancet 1:257 (1981).PubMedCrossRefGoogle Scholar
  3. 3.
    J. E. Dalen, R. J. Goldberg, J. M. Gore, and J. Struckus, Therapeutic interventions in acute myocardial infarction. Survey of the ACCP Section on Clinical Cardiology, Chest 86:257 (1984).PubMedCrossRefGoogle Scholar
  4. 4.
    R. J. Goldberg, J. M. Gore, and J. E. Dalen. The role of anticoagulant therapy in acute myocardial infarction, Am. Heart J. 108:1387 (1984).PubMedCrossRefGoogle Scholar
  5. 5.
    J. H. Chesebro, M. Ezekowitz, L. Badimon, and V. Fuster, Intracardiac thrombi and systemic thromboembolism: detection, incidence, and treatment, Ann. Rev. Med. 36:579 (1985).PubMedCrossRefGoogle Scholar
  6. 6.
    L. Resnekov, J. Chediak, J. Hirsh, and D. Lewis, Antithrombotic agents in coronary artery disease, Chest 89 (supplement 2) :54S (1986)Google Scholar
  7. 7.
    R. S. Meltzer, C. A. Visser, and V. Fuster, Intracardiac thrombi and systemic embolization, Ann. Int. Med. 104:689 (1986).PubMedCrossRefGoogle Scholar
  8. 8.
    W. B. Bean, Infarction of the heart. III. Clinical course and morphological findings, Ann. Int. Med. 12:71 (1938).CrossRefGoogle Scholar
  9. 9.
    H. K. Hellerstein, and J. W. Martin, Incidence of thrombo-embolic lesions accompanying myocardial infarction, Am. Heart J. 33:443 (1947).PubMedCrossRefGoogle Scholar
  10. 10.
    Anticoagulants in acute myocardial infarction: results of a cooperative clinical trial, JAMA 225:724 (1973).Google Scholar
  11. 11.
    Assessment of short-term anticoagulant administration after cardiac infarction. Report of the working party on anticoagulant therapy in coronary thrombosis to the Medical Research Council, Br. Med. J. 1:335 (1969).CrossRefGoogle Scholar
  12. 12.
    A. Drapkin and C. Merskey, Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient’s age sex, and severity of infarction, JAMA 222:541 (1972).PubMedCrossRefGoogle Scholar
  13. 13.
    P. L. Thompson and J. S. Robinson, Stroke after acute myocardial infarction: relation to infarct size, Br. Med. J. 2:457 (1978).PubMedCrossRefGoogle Scholar
  14. 14.
    A. N. DeMaria, W. Bommer, A. Neumann, T. Grehl, L. Weinart, S. DeNardo, E. A. Amsterdam and D. T. Mason, Left ventricular thrombi identified by cross-sectional echocardiography, Ann. Int. Med. 90:14 (1979).CrossRefGoogle Scholar
  15. 15.
    R. W. Asinger, F. L. Mikell, B. Sharma, and M. Hodges, Observations on detecting left ventricular thrombus with two dimensional echocardiography: emphasis on avoidance of false positive diagnoses, Am. J. Cardiol. 47:145 (1981).PubMedCrossRefGoogle Scholar
  16. 16.
    R. W. Asinger, F. L. Mikell, J. Elsperger, and M. Hodges, Incidence of left ventricular thrombosis after acute transmural myocardial infarction, N. Engl. J. Med. 305:297 (1981).PubMedCrossRefGoogle Scholar
  17. 17.
    D. J. Weinreich, J. F. Burke and F. J. Pauletto, Left ventricular mural thrombi complicating acute myocardial infarction. Long term follow up with serial echocardiographym, Ann. Int. Med. 100:789 (1984).PubMedCrossRefGoogle Scholar
  18. 18.
    K. A. Johannessen, J. E. Nordrehaug, and G. von der Lippe, Left ventricular thrombosis and cerebrovascular accident in acute myocardial infarction, Br. Heart J. 51:557 (1984).CrossRefGoogle Scholar
  19. 19.
    E. C. Keating, S. A. Gross, R. A. Schlamowitz, J. Glassman, J. H. Mazur, W. A. Pitt and D. Miller, Mural thrombi in myocardial infarctions. Prospective evaluation by two-dimensional echocardiography, Am. J. Med. 74:989 (1983).PubMedCrossRefGoogle Scholar
  20. 20.
    J. E. Nordrehaug, K.-A. Johannessen, and G. von der Lippe, usefulness of high-dose anticoagulants in preventing left ventricular thrombus in acute myocardial infarction, Am. J. Cardiol. 55:1491 (1985).PubMedCrossRefGoogle Scholar
  21. 21.
    P. Spirito, P. Bellotti, F. Chiarella, S. Domenicucci, A. Sementa, and C. Vecchio, Prognostic significance and natural history of left ventricular thrombi in patients with acute anterior myocardial infarction: a two-dimensional echocardiographic study, Circ. 72:774 (1985).CrossRefGoogle Scholar
  22. 22.
    H. S. Cabin and W. C. Roberts, Left ventricular aneurysm, intraaneurysmal thrombus and systemic embolus in coronary heart disease, Chest 77:586 (1980).PubMedCrossRefGoogle Scholar
  23. 23.
    R. S. Meltzer, C. A. Visser, G. Kan, and J. Roelandt, Two-dimensional echocardiographic appearance of left ventricular thrombi with systemic emboli after myocardial infarction, Am. J. Cardiol. 53:1511 (1984).PubMedCrossRefGoogle Scholar
  24. 24.
    J. M. Haugland, R. W. Asinger, F. L. Mikell, J. Elsperger, M. Hodges, Embolic potential of left ventricular thrombi detected by two-dimensional echocardiography, Circ. 70:588 (1984).CrossRefGoogle Scholar
  25. 25.
    C. A. Visser, G. Kan, R. S. Meltzer, K. I. Lie, and D. Durrer. Long-term follow-up of left ventricular thrombus after acute myocardial infarction. A two-dimensional echocardiographic study in 96 patients, Chest 86:532 (1984).PubMedCrossRefGoogle Scholar
  26. 26.
    J. Hirsh, D. Deykin, and L. Poller, “Therapeutic range” for oral anticoagulant therapy, Chest 89(Supplement 2):11S (1986).Google Scholar
  27. 27.
    J. V. Nixon, Left ventricular mural thrombus, Arch. Int. Med. 143:1567 (1983).CrossRefGoogle Scholar
  28. 28.
    M. D. Ezekowitz, Acute infarction, left ventricular thrombus and systemic embolization: an approach to management, JACC 5:1281 (1985).PubMedCrossRefGoogle Scholar
  29. 29.
    E. L. Kinney, The significance of left ventricular thrombi in patients with coronary heart disease: A retrospective analysis of pooled data, Am. Heart J. 109:191 (1985)PubMedCrossRefGoogle Scholar
  30. 30.
    Norwegian Multicenter Group, Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction, N. Engl. J. Med. 304:801 (1981).CrossRefGoogle Scholar
  31. 31.
    B. Sharma, A. Carvalho, R. Wyeth, and J. A. Franciosa, Left ventricular thrombi diagnosed by echocardiography in patients with acute myocardial infarction treated with intracoronary streptokinase followed by intravenous heparin, Am. J. Cardiol. 56:422 (1985).PubMedCrossRefGoogle Scholar
  32. 32.
    J. Paraskos, Personal communication.Google Scholar
  33. 33.
    N. Eigler, G. Maurer, and P. K. Shah, Effect of early systemic thrombolytic therapy on left ventricular mural thrombus formation in acute anterior myocardial infarction, Am J. Cardiol. 54:261 (1984).PubMedCrossRefGoogle Scholar
  34. 34.
    D. G. Sherman, M. L. Dyken, M. Fisher, M. J. G. Harrison, and R. G. Hart. Cerebral embolism, Chest 89(supplement 2):82S (1986).Google Scholar
  35. 35.
    J. H. Chesebro, V. Fuster, L. R. Elveback, D. C. McGoon, J.R. Pluth, F. J. Puga, R. B. Wallace, G. K. Danielson, T. A. Orszulak, J. M. Pehler, and H. V. Schaff. Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole, Am. J. Cardiol. 51:1537 (1983).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Daniel Deykin
    • 1
  1. 1.Cooperative Studies Program (151-I)VA Medical CenterBostonUSA

Personalised recommendations